Vine Ventures

Vine Ventures, founded in 2019 by Ryan Zurrer, is a venture capital firm headquartered in Zurich, Switzerland, with a strong focus on early-stage investments in the life sciences and technology sectors. The firm has a particular interest in innovative solutions for mental health and wellness, emphasizing the development of psychedelic therapies and healthcare technology systems. Notable investments from Vine Ventures include companies like Alto Neuroscience, which recently went public, and Kocomo, a proptech startup based in Mexico City. Vine Ventures has also backed Remepy, Lykos Therapeutics, and Necto, demonstrating their commitment to advancing healthcare and financial software solutions. Geographically, Vine Ventures invests in the U.S., Latin America, and Israel, reflecting their global reach and diversified portfolio. Their strategic approach involves leading funding rounds and providing substantial support to help startups scale and achieve significant milestones​. The Vine Ventures team boasts experienced professionals like Daniel Tarockoff and Ozan Polat, based in San Francisco and Zurich respectively. Ryan Zurrer, the founder, has a robust background in venture investing and entrepreneurship, particularly in the renewable energy and blockchain sectors. This diverse expertise allows the firm to offer valuable insights and hands-on support to their portfolio companies​. For startups aiming to collaborate with Vine Ventures, it's essential to present innovative, scalable solutions that align with their focus areas. Direct, concise pitches that demonstrate clear market potential and strategic fit are highly valued by the firm. By fostering a collaborative environment and leveraging their extensive network, Vine Ventures continues to drive impactful advancements in the health and wellness sectors.